US 10344096
Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
granted A61KA61K2039/505A61K2039/6081
Quick answer
US patent 10344096 (Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis) held by The Regents of the University of California expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K2039/6081, A61K39/001102, A61P